Literature DB >> 7716176

Distribution and retention of nicotine and its metabolite, cotinine, in the rat as a function of time.

B V Sastry1, M B Chance, G Singh, J L Horn, V E Janson.   

Abstract

Nicotine is oxidized to its major metabolite, cotinine, which has a long biological half-life (19-24 h). The plasma concentration of cotinine has been used as an index of tobacco smoke exposure. Cotinine possibly increases the turnover rate of platelet-activating factor (PAF) because it is a potent activator of PAF hydrolase, and it may play a significant role in tobacco-induced arterial thrombosis. Therefore, we studied the distribution and retention of nicotine as it was metabolized to cotinine in the rat. Nicotine (1 mg/kg, 5 microCi/kg) was administered into the femoral vein of male Sprague-Dawley rats under nembutal anesthesia. At different times (5-60 min) after nicotine administration, nicotine and its metabolite, cotinine, were determined by HPLC in plasma, liver, kidney, heart and brain. Within 5-10 min after administration, nicotine concentrations reached peak values in plasma (2,160 pmol/ml) and the organs analyzed. The plasma level of nicotine decreased by 50% within 20 min (half-time) after its intravenous administration. The half-time of nicotine in the brain was about 50 min. The half-times of nicotine for the other organs were about 20-25 min. The major metabolite, cotinine, accumulated in plasma, and by about 30 min the concentrations of nicotine and cotinine in plasma were about equal (890-1,000 pmol/ml). While cotinine accumulated in plasma, nicotine was eliminated by the kidney. While the nicotine concentrations decreased with time in all organs, cotinine concentrations remained constant. These observations indicate that nicotine is renally eliminated or metabolized to cotinine while cotinine exhibits a long retention time and accumulates in plasma.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7716176     DOI: 10.1159/000139274

Source DB:  PubMed          Journal:  Pharmacology        ISSN: 0031-7012            Impact factor:   2.547


  11 in total

1.  Pharmacokinetics of cotinine in rats: a potential therapeutic agent for disorders of cognitive function.

Authors:  Pei Li; Wayne D Beck; Patrick M Callahan; Alvin V Terry; Michael G Bartlett
Journal:  Pharmacol Rep       Date:  2014-12-16       Impact factor: 3.024

2.  Nicotine modulates alcohol-seeking and relapse by alcohol-preferring (P) rats in a time-dependent manner.

Authors:  Sheketha R Hauser; Bruk Getachew; Scott M Oster; Ronnie Dhaher; Zheng-Ming Ding; Richard L Bell; William J McBride; Zachary A Rodd
Journal:  Alcohol Clin Exp Res       Date:  2011-06-20       Impact factor: 3.455

3.  Influence of developmental nicotine exposure on spike-timing precision and reliability in hypoglossal motoneurons.

Authors:  Gregory L Powell; Richard B Levine; Amanda M Frazier; Ralph F Fregosi
Journal:  J Neurophysiol       Date:  2014-12-30       Impact factor: 2.714

4.  Pre-Exposure to Nicotine with Nocturnal Abstinence Induces Epigenetic Changes that Potentiate Nicotine Preference.

Authors:  Antonella Pisera-Fuster; Maria Paula Faillace; Ramon Bernabeu
Journal:  Mol Neurobiol       Date:  2019-12-17       Impact factor: 5.590

5.  Preadolescent tobacco smoke exposure leads to acute nicotine dependence but does not affect the rewarding effects of nicotine or nicotine withdrawal in adulthood in rats.

Authors:  Hidetaka Yamada; Mahendra Bishnoi; Kim F M Keijzers; Irma A van Tuijl; Elysia Small; Hina P Shah; Rayna M Bauzo; Firas H Kobeissy; Sreedharan N Sabarinath; Hartmut Derendorf; Adrie W Bruijnzeel
Journal:  Pharmacol Biochem Behav       Date:  2010-03-06       Impact factor: 3.533

6.  Influence of developmental nicotine exposure on the ventilatory and metabolic response to hyperthermia.

Authors:  Jonathan Ferng; Ralph F Fregosi
Journal:  J Physiol       Date:  2015-12-01       Impact factor: 5.182

7.  Nicotine-induced neuroplasticity counteracts the effect of schizophrenia-linked neuregulin 1 signaling on NMDAR function in the rat hippocampus.

Authors:  Yoshihiko Yamazaki; Katumi Sumikawa
Journal:  Neuropharmacology       Date:  2016-10-23       Impact factor: 5.250

8.  Chronic co-administration of nicotine and methamphetamine causes differential expression of immediate early genes in the dorsal striatum and nucleus accumbens of rats.

Authors:  F Saint-Preux; L R Bores; I Tulloch; B Ladenheim; R Kim; P K Thanos; N D Volkow; J L Cadet
Journal:  Neuroscience       Date:  2013-04-03       Impact factor: 3.590

9.  Intravenous nicotine injection induces rapid, experience-dependent sensitization of glutamate release in the ventral tegmental area and nucleus accumbens.

Authors:  Magalie Lenoir; Eugene A Kiyatkin
Journal:  J Neurochem       Date:  2013-10-21       Impact factor: 5.372

10.  From smoking to cancers: novel targets to neuronal nicotinic acetylcholine receptors.

Authors:  Chia-Hwa Lee; Chih-Hsiung Wu; Yuan-Soon Ho
Journal:  J Oncol       Date:  2011-04-28       Impact factor: 4.375

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.